zydus cadila

Portland, OR, Nov. 01, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Chronic Hepatitis B (CHB) Market size was estimated at $4.6 billion in 2021 and is expected to hit $6.1 billion by…

Pharmaceutical company Zydus group on Wednesday announced that it had started the supply of its COVID-19 vaccine, ZyCoV-D, to the Central government against their order. The group is also planning to make the vaccine available in the…

The vaccine is a three-dose one administered intradermally using the painless PharmaJet, a needle-free system, Tropis, on Day 0, Day 28 and Day 56. Zydus Cadila on Wednesday announced that the company had started supplies of its Covid-19…

Nasal vaccine is administered through the nose and not syringe making it easy for application to children. It can generate an immune response at the site of infection within respiratory passage starting from nasal airways and is most…

By Aarushi BatraAs the Drugs Controller General of India (DCGI) granted Emergency Use Authorization (EUA) to Zydus Cadila’s ZyCoV-D vaccine and Subject Expert Committee (SEC) recommended DCGI to approve Covaxin for kids, COVID vaccines…

Bharat Biotech thanked the DCGI, SEC and CDSCO for expediting the review process. (Representational image)The vaccine Subject Expert Committee (SEC) on Tuesday recommended granting of emergency use authorisation (EUA) for vaccine maker…

Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI) for further approvals.Even as India’s cumulative…

A total of 90 children were subjected to Covaxin trials in Karnataka. ‘Zydus Cadila, a leading pharmaceutical company in India was recently authorized by DCGI for its needle-free ZyCoV-D Covid-19 vaccine for the children aged 12 years and…

According to Patel, Zydus Cadila had invested Rs 500 crore in developing the vaccine and in the manufacturing capacity with further investments expected as manufacturing capacity was being ramped up. The company had secured raw materials…

The Central Drugs Standard Control Organization's Subject Expert Committee has granted Zydus Cadila's three-dose vaccine emergency use authorization in India. The vaccine can be administered to people aged 12 and above. ‘Phase 3 clinical…